Complications, adverse drug events, high costs, disparities in multisystem inflammatory syndrome in children vs COVID-19

 In this study of 4,100 multisystem inflammatory syndrome in children (MIS-C) hospitalizations in 2021, MIS-C was more common and severe than previously reported, with more racial disparities in outcomes than were seen in patients with COVID-19. The findings of this study suggest that relying on mean outcomes for MIS-C from past studies can be misleading, since outcomes and disparities varied widely with the number of multiorgan dysfunctions.  

Authors: William Encinosa, Ph.D., of the Agency for Healthcare Research and Quality in Rockville, Maryland, is the corresponding author. 

 To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2022.44975)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.44975?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010523